Enhanced metabolism of mexiletine after phenytoin administration

Br J Clin Pharmacol. 1982 Aug;14(2):219-23. doi: 10.1111/j.1365-2125.1982.tb01965.x.

Abstract

1 Unexpectedly low plasma concentrations of mexiletine were observed in three patients treated with mexiletine and concurrently taking phenytoin. 2 Six healthy volunteers were given a single oral dose of mexiletine (400 mg), before and after 1 week of phenytoin administration (300 mg/day). 3 The mean +/- s.d. area under the plasma mexiletine concentration-time curve decreased from 17.67 +/- 6.21 to 8.01 +/- 3.64 micrograms ml-1 h (P less than 0.003). 4 The mean +/- s.d. half-life of elimination of mexiletine decreased from 17.2 +/- 5.26 to 8.4 +/- 4.17 h (P less than 0.02) 5 The suggested mechanism of the interaction is hepatic mixed-function oxidase enzyme induction by phenytoin. 6 The interaction is likely to be clinically significant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biological Availability
  • Drug Interactions
  • Female
  • Humans
  • Kinetics
  • Male
  • Mexiletine / metabolism*
  • Phenytoin / pharmacology*
  • Propylamines / metabolism*

Substances

  • Propylamines
  • Mexiletine
  • Phenytoin